Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Post-Transplant Events

Inflammatory responses after intracoronary mononuclear BM cell therapy in swine

Abstract

The aim of this study was to investigate the influence of intracoronary injection of mononuclear BM cells (mBMCs) on inflammatory mediators in swine with acute myocardial infarction (AMI) in two groups. Group 1 received the therapy immediately after AMI, but group 2 received it after 3 weeks. The levels of cytokines and heart functions, respectively, were examined 3 weeks after cell therapy. The serum levels of TNF-α and IL-8 were significantly lower than in the control group: in contrast, IL-10 was significantly elevated in the cell recipients, especially in group 1. TNF-α correlated with IL-8 between groups. The ventricular functions were significantly improved. These results show that although the intracoronary injection of mBMCs induces a marked short-term inflammatory response in the acute stage, mBMCs may play an anti-inflammatory role topically and systematically and early cell therapy may be preferable.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

References

  1. Assmus B, Schächinger V, Teupe C, Britten M, Lehmann R, Döbert N et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002; 106: 3009–3017.

    Article  PubMed  Google Scholar 

  2. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364: 141–148.

    Article  PubMed  Google Scholar 

  3. Ince H, Petzsch M, Kleine HD, Eckard H, Rehders T, Burska D et al. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial. Circulation 2005; 112 (Suppl): I73–I80.

    PubMed  Google Scholar 

  4. Soonpaa MH, Koh GY, Klug MG, Field LJ . Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 1994; 264: 98–101.

    Article  CAS  PubMed  Google Scholar 

  5. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41–49.

    Article  CAS  PubMed  Google Scholar 

  6. Slack JM . Stem cells in epithelial tissues. Science 2000; 287: 1431–1433.

    Article  CAS  PubMed  Google Scholar 

  7. Vandervelde S, van Luyn MJ, Tio RA, Harmsen MC . Signaling factors in stem cell-mediated repair of infarcted myocardium. J Mol Cell Cardiol 2005; 39: 363–376.

    Article  CAS  PubMed  Google Scholar 

  8. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC . Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004; 428: 668–673.

    Article  CAS  PubMed  Google Scholar 

  9. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428: 664–668.

    Article  CAS  PubMed  Google Scholar 

  10. Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, Bearzi C et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 2005; 96: 127–137.

    Article  CAS  PubMed  Google Scholar 

  11. Martins TB, Anderson JL, Muhlestein JB, Horne BD, Carlquist JF, Roberts WL et al. Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay. Am J Clin Pathol 2006; 125: 906–913.

    Article  CAS  PubMed  Google Scholar 

  12. Akasaka Y, Morimoto N, Ishikawa Y, Fujita K, Ito K, Kimura-Matsumoto M et al. Myocardial apoptosis associated with the expression of proinflammatory cytokines during the course of myocardial infarction. Mod Pathol 2006; 19: 588–598.

    Article  CAS  PubMed  Google Scholar 

  13. Shan K, Kurrelmeyer K, Seta Y, Wang F, Dibbs Z, Deswal A et al. The role of cytokines in disease progression in heart failure. Curr Opin Cardiol 1997; 12: 218–223.

    Article  CAS  PubMed  Google Scholar 

  14. Wang P, Wu P, Siegel MI, Egan RW, Billah MM . Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995; 270: 9558–9563.

    Article  CAS  PubMed  Google Scholar 

  15. Chalikias GK, Tziakas DN, Kaski JC, Kekes A, Hatzinikolaou EI, Stakos DA et al. Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome. Int J Cardiol 2007; 117: 333–339.

    Article  PubMed  Google Scholar 

  16. Tziakas DN, Chalikias GK, Antonoglou CO, Veletza S, Tentes IK, Kortsaris AX et al. Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease. J Am Coll Cardiol 2006; 48: 2471–2481.

    Article  CAS  PubMed  Google Scholar 

  17. Welt FG, Losordo DW . Cell therapy for acute myocardial infarction: curb your enthusiasm? Circulation 2006; 113: 1272–1274.

    Article  PubMed  Google Scholar 

  18. Frangogiannis NG, Smith CW, Entman ML . The inflammatory response in myocardial infarction. Cardiovasc Res 2002; 53: 31–47.

    Article  CAS  PubMed  Google Scholar 

  19. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Forfang K, ASTAMI investigators. Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects. Scand Cardiovasc J 2005; 39: 150–158.

    Article  CAS  PubMed  Google Scholar 

  20. Lunde K, Solheim S, Aakhus S, Arnesen H, Moum T, Abdelnoor M et al. Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial. Am Heart J 2007; 154: 710.e1–710.e8.

    Article  Google Scholar 

  21. Solheim S, Seljeflot I, Lunde K, Aukrust P, Yndestad A, Grøgaard HK et al. Inflammatory responses after intracoronary injection of autologous mononuclear bone marrow cells in patients with acute myocardial infarction. Am Heart J 2008; 155: 55.e1–55.e9.

    Article  Google Scholar 

Download references

Acknowledgements

This study was supported by the National Science Project (No. 2004BA714B-1).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W Gao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xu, S., Xu, X., Guo, Y. et al. Inflammatory responses after intracoronary mononuclear BM cell therapy in swine. Bone Marrow Transplant 44, 427–431 (2009). https://doi.org/10.1038/bmt.2009.52

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2009.52

Keywords

This article is cited by

Search

Quick links